Richard-Carpentier G. Venetoclax-based lower-intensity regimens for acute myeloid leukemia: Clinical pearls for a new standard of care. Can Hematol Today [Internet]. 2023 Mar. 1 [cited 2024 Apr. 23];2(1):28–33. Available from: https://canadianhematologytoday.com/article/view/2-1-5-richard-carpentier